Unveiling the Potential of RN7SL455P as a Drug Target or Biomarker

Target Name: RN7SL455P

NCBI ID: G106479389

RN7SL455P

Other Name(s): RNA, 7SL, cytoplasmic 455, pseudogene

Unveiling the Potential of RN7SL455P as a Drug Target or Biomarker

Introduction

The RNA-protein complex, composed of RNA and protein molecules, plays a crucial role in various cellular processes. One of the well-known RNA-protein interactions is the cytoplasmic 455-like structure (c455), which has been observed in various organisms . RN7SL455P, a specific RNA molecule, has been identified as a potential drug target or biomarker, and its functional implications have been explored in this article.

RNA Structure and Function

RN7SL455P is a 21-nucleotide RNA molecule with a unique 7-slice structure. It contains a single exon that encodes the protein coding gene (1-segment), but with an additional exon that does not code for any protein. The 7-slice The structure consists of a core-like region, which encodes the 5'-end of the RNA, and six exonic regions that encode the 3'-end of the RNA.

RN7SL455P has been shown to have various cellular processes involved in its structure and function. Firstly, it is involved in the regulation of gene expression. Studies have shown that RN7SL455P can act as a scaffold to recruit various RNA-protein interactions, including those with known protein-protein interaction modules, such as the nucleosome and the nucleolus. Secondly, RN7SL455P is associated with various cellular signaling pathways, including the regulation of cell growth, apoptosis, and inflammation.

Potential Drug Target

The unique 7-slice structure of RN7SL455P makes it an attractive drug target. The protein coding region has multiple potential druggable residues, including a conserved G/C-rich region, a lysine residue, and a Glu-rich region. Chemical inhibitors have been shown to interact with these residues and alter the stability of the RNA molecule. Therefore, RN7SL455P may be a suitable target for small molecules or antibodies that can modulate its stability or activity.

In addition to its potential drug target, RN7SL455P also has the potential to serve as a biomarker. The cytoplasmic 455-like structure is a well-established biomarker for various diseases, including cancer, neurodegenerative diseases, and genetic disorders. The detection and quantification of the c455-like structure can provide valuable information about the levels of disease-related RNAs in the cell, which may be used to diagnose or monitor the disease.

Conclusion

In conclusion, RN7SL455P is a unique RNA molecule with various cellular processes involved in its structure and function. Its 7-slice structure and unique protein coding region make it an attractive drug target or biomarker. Further studies are needed to explore its drug potential targeting and diagnostic applications.

Protein Name: RNA, 7SL, Cytoplasmic 455, Pseudogene

The "RN7SL455P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RN7SL455P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets